ID   S38A1_HUMAN             Reviewed;         487 AA.
AC   Q9H2H9; Q8NC61; Q8NCF8; Q96JX2; Q9H2Q2;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 125.
DE   RecName: Full=Sodium-coupled neutral amino acid transporter 1;
DE   AltName: Full=Amino acid transporter A1;
DE   AltName: Full=N-system amino acid transporter 2;
DE   AltName: Full=Solute carrier family 38 member 1;
DE   AltName: Full=System A amino acid transporter 1;
DE   AltName: Full=System N amino acid transporter 1;
GN   Name=SLC38A1; Synonyms=ATA1, NAT2, SAT1, SNAT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=10891391; DOI=10.1006/bbrc.2000.3061;
RA   Wang H., Huang W., Sugawara M., Devoe L.D., Leibach F.H., Prasad P.D.,
RA   Ganapathy V.;
RT   "Cloning and functional expression of ATA1, a subtype of amino acid
RT   transporter A, from human placenta.";
RL   Biochem. Biophys. Res. Commun. 273:1175-1179(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hypothalamus;
RA   Xu X., Yang Y., Gao G., Xiao H., Chen Z., Han Z.;
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12388062; DOI=10.1152/ajpcell.00253.2002;
RA   Nelson D.M., Smith S.D., Furesz T.C., Sadovsky Y., Ganapathy V.,
RA   Parvin C.A., Smith C.H.;
RT   "Hypoxia reduces expression and function of system A amino acid
RT   transporters in cultured term human trophoblasts.";
RL   Am. J. Physiol. 284:C310-C315(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15054072; DOI=10.1093/cercor/bhh018;
RA   Melone M., Quagliano F., Barbaresi P., Varoqui H., Erickson J.D.,
RA   Conti F.;
RT   "Localization of the glutamine transporter SNAT1 in rat cerebral
RT   cortex and neighboring structures, with a note on its localization in
RT   human cortex.";
RL   Cereb. Cortex 14:562-574(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=16148032; DOI=10.1152/ajpcell.00258.2005;
RA   Desforges M., Lacey H.A., Glazier J.D., Greenwood S.L., Mynett K.J.,
RA   Speake P.F., Sibley C.P.;
RT   "SNAT4 isoform of system A amino acid transporter is expressed in
RT   human placenta.";
RL   Am. J. Physiol. 290:C305-C312(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   INDUCTION BY LPS.
RX   PubMed=16583402; DOI=10.1002/jnr.20855;
RA   Ogura M., Nakamichi N., Takano K., Oikawa H., Kambe Y., Ohno Y.,
RA   Taniura H., Yoneda Y.;
RT   "Functional expression of a glutamine transporter responsive to down-
RT   regulation by lipopolysaccharide through reduced promoter activity in
RT   cultured rat neocortical astrocytes.";
RL   J. Neurosci. Res. 83:1447-1460(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25; SER-28; SER-52;
RP   THR-54 AND SER-56, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; THR-54 AND SER-56,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52 AND THR-54, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-52 AND SER-56,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Functions as a sodium-dependent amino acid transporter.
CC       Mediates the saturable, pH-sensitive and electrogenic cotransport
CC       of glutamine and sodium ions with a stoichiometry of 1:1. May also
CC       transport small zwitterionic and aliphatic amino acids with a
CC       lower affinity. May supply glutamatergic and GABAergic neurons
CC       with glutamine which is required for the synthesis of the
CC       neurotransmitters glutamate and GABA.
CC       {ECO:0000269|PubMed:10891391}.
CC   -!- ENZYME REGULATION: Inhibited by potassium, choline ions and 2-
CC       methylamino-isobutyric acid (MeAIB) (By similarity). Inhibited by
CC       lithium and N-methyl-D-glucamine. {ECO:0000250,
CC       ECO:0000269|PubMed:10891391}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=890 uM for 2-methylamino-isobutyric acid (MeAIB) (at pH 8.5)
CC         {ECO:0000269|PubMed:10891391};
CC   -!- INTERACTION:
CC       Q969F0:FATE1; NbExp=5; IntAct=EBI-9978441, EBI-743099;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15054072};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:15054072}.
CC       Note=Restricted to the somatodendritic compartment of neurons.
CC       Found in the cellular processes of neurons in the developing brain
CC       (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in the cerebral cortex by pyramidal
CC       and GABAergic neurons, astrocytes and other non-neuronal cells (at
CC       protein level). Expressed in placenta, heart, lung, skeletal
CC       muscle, spleen, stomach and testis. {ECO:0000269|PubMed:10891391,
CC       ECO:0000269|PubMed:12388062, ECO:0000269|PubMed:15054072,
CC       ECO:0000269|PubMed:16148032}.
CC   -!- INDUCTION: Down-regulated by bacterial lipopolysaccharides (LPS)
CC       in glial cells. Down-regulated upon hypoxia.
CC       {ECO:0000269|PubMed:12388062, ECO:0000269|PubMed:16583402}.
CC   -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG44546.1; Type=Frameshift; Positions=443; Evidence={ECO:0000305};
CC       Sequence=BAC11186.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF271070; AAG39354.1; -; mRNA.
DR   EMBL; AF247166; AAG44546.1; ALT_FRAME; mRNA.
DR   EMBL; AK027825; BAB55394.1; -; mRNA.
DR   EMBL; AK074758; BAC11186.1; ALT_INIT; mRNA.
DR   EMBL; AK074949; BAC11310.1; -; mRNA.
DR   EMBL; CH471111; EAW57895.1; -; Genomic_DNA.
DR   EMBL; BC010620; AAH10620.1; -; mRNA.
DR   CCDS; CCDS41774.1; -.
DR   PIR; JC7328; JC7328.
DR   RefSeq; NP_001070952.1; NM_001077484.1.
DR   RefSeq; NP_001265316.1; NM_001278387.1.
DR   RefSeq; NP_001265317.1; NM_001278388.1.
DR   RefSeq; NP_001265318.1; NM_001278389.1.
DR   RefSeq; NP_109599.3; NM_030674.3.
DR   UniGene; Hs.533770; -.
DR   ProteinModelPortal; Q9H2H9; -.
DR   BioGrid; 123509; 6.
DR   IntAct; Q9H2H9; 72.
DR   STRING; 9606.ENSP00000381634; -.
DR   TCDB; 2.A.18.6.14; the amino acid/auxin permease (aaap) family.
DR   iPTMnet; Q9H2H9; -.
DR   PhosphoSitePlus; Q9H2H9; -.
DR   SwissPalm; Q9H2H9; -.
DR   BioMuta; SLC38A1; -.
DR   DMDM; 74733561; -.
DR   EPD; Q9H2H9; -.
DR   MaxQB; Q9H2H9; -.
DR   PaxDb; Q9H2H9; -.
DR   PeptideAtlas; Q9H2H9; -.
DR   PRIDE; Q9H2H9; -.
DR   DNASU; 81539; -.
DR   Ensembl; ENST00000398637; ENSP00000381634; ENSG00000111371.
DR   Ensembl; ENST00000439706; ENSP00000398142; ENSG00000111371.
DR   Ensembl; ENST00000546893; ENSP00000447853; ENSG00000111371.
DR   Ensembl; ENST00000549049; ENSP00000449607; ENSG00000111371.
DR   GeneID; 81539; -.
DR   KEGG; hsa:81539; -.
DR   UCSC; uc001rpb.5; human.
DR   CTD; 81539; -.
DR   DisGeNET; 81539; -.
DR   GeneCards; SLC38A1; -.
DR   HGNC; HGNC:13447; SLC38A1.
DR   HPA; HPA039460; -.
DR   HPA; HPA052272; -.
DR   MIM; 608490; gene.
DR   neXtProt; NX_Q9H2H9; -.
DR   OpenTargets; ENSG00000111371; -.
DR   PharmGKB; PA37772; -.
DR   eggNOG; KOG1305; Eukaryota.
DR   eggNOG; COG0814; LUCA.
DR   GeneTree; ENSGT00760000119147; -.
DR   HOGENOM; HOG000013088; -.
DR   HOVERGEN; HBG059571; -.
DR   InParanoid; Q9H2H9; -.
DR   KO; K14990; -.
DR   PhylomeDB; Q9H2H9; -.
DR   TreeFam; TF328787; -.
DR   Reactome; R-HSA-210455; Astrocytic Glutamate-Glutamine Uptake And Metabolism.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC38A1; human.
DR   GeneWiki; SLC38A1; -.
DR   GenomeRNAi; 81539; -.
DR   PRO; PR:Q9H2H9; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111371; -.
DR   CleanEx; HS_NAT2; -.
DR   CleanEx; HS_SAT1; -.
DR   CleanEx; HS_SLC38A1; -.
DR   ExpressionAtlas; Q9H2H9; baseline and differential.
DR   Genevisible; Q9H2H9; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; NAS:UniProtKB.
DR   GO; GO:0005283; F:sodium:amino acid symporter activity; NAS:UniProtKB.
DR   GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0001504; P:neurotransmitter uptake; TAS:Reactome.
DR   GO; GO:0015804; P:neutral amino acid transport; NAS:UniProtKB.
DR   InterPro; IPR013057; AA_transpt_TM.
DR   Pfam; PF01490; Aa_trans; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Cell membrane; Complete proteome; Glycoprotein;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1    487       Sodium-coupled neutral amino acid
FT                                transporter 1.
FT                                /FTId=PRO_0000310475.
FT   TOPO_DOM      1     74       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     75     97       Helical. {ECO:0000255}.
FT   TOPO_DOM     98    112       Extracellular. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TOPO_DOM    134    147       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255}.
FT   TOPO_DOM    169    188       Extracellular. {ECO:0000255}.
FT   TRANSMEM    189    211       Helical. {ECO:0000255}.
FT   TOPO_DOM    212    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TOPO_DOM    238    275       Extracellular. {ECO:0000255}.
FT   TRANSMEM    276    296       Helical. {ECO:0000255}.
FT   TOPO_DOM    297    312       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    313    333       Helical. {ECO:0000255}.
FT   TOPO_DOM    334    350       Extracellular. {ECO:0000255}.
FT   TRANSMEM    351    371       Helical. {ECO:0000255}.
FT   TOPO_DOM    372    393       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    394    414       Helical. {ECO:0000255}.
FT   TOPO_DOM    415    416       Extracellular. {ECO:0000255}.
FT   TRANSMEM    417    437       Helical. {ECO:0000255}.
FT   TOPO_DOM    438    452       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    453    473       Helical. {ECO:0000255}.
FT   TOPO_DOM    474    487       Extracellular. {ECO:0000255}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K2P7}.
FT   MOD_RES      11     11       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8K2P7}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      28     28       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      54     54       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES      56     56       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    251    251       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    107    107       L -> P (in Ref. 3; BAB55394).
FT                                {ECO:0000305}.
FT   CONFLICT    203    203       F -> V (in Ref. 4; BAC11310).
FT                                {ECO:0000305}.
FT   CONFLICT    375    375       V -> D (in Ref. 2; AAG44546).
FT                                {ECO:0000305}.
FT   CONFLICT    483    484       SD -> NG (in Ref. 2; AAG44546).
FT                                {ECO:0000305}.
SQ   SEQUENCE   487 AA;  54048 MW;  5CBC96880D7BDE03 CRC64;
     MMHFKSGLEL TELQNMTVPE DDNISNDSND FTEVENGQIN SKFISDRESR RSLTNSHLEK
     KKCDEYIPGT TSLGMSVFNL SNAIMGSGIL GLAFALANTG ILLFLVLLTS VTLLSIYSIN
     LLLICSKETG CMVYEKLGEQ VFGTTGKFVI FGATSLQNTG AMLSYLFIVK NELPSAIKFL
     MGKEETFSAW YVDGRVLVVI VTFGIILPLC LLKNLGYLGY TSGFSLSCMV FFLIVVIYKK
     FQIPCIVPEL NSTISANSTN ADTCTPKYVT FNSKTVYALP TIAFAFVCHP SVLPIYSELK
     DRSQKKMQMV SNISFFAMFV MYFLTAIFGY LTFYDNVQSD LLHKYQSKDD ILILTVRLAV
     IVAVILTVPV LFFTVRSSLF ELAKKTKFNL CRHTVVTCIL LVVINLLVIF IPSMKDIFGV
     VGVTSANMLI FILPSSLYLK ITDQDGDKGT QRIWAALFLG LGVLFSLVSI PLVIYDWACS
     SSSDEGH
//
